道琼斯指数
52,396.97
涨跌
+165.08+0.32%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 +0.32%,标普 500 指数为 +1.50%,纳斯达克综合指数为 +2.13%。个股方面,2,384 只上涨、2,727 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | DBV Technologies S.A.DBVT | $11.83 | +3.82% | 151.30K | $743.84M | $8.63 - $26.18 | 0.00% |
| 52 | Cullinan Oncology LLCCGEM | $11.38 | +1.25% | 270.69K | $732.42M | $7.25 - $23.19 | 0.00% |
| 53 | Candel TherapeuticsCADL | $9.46 | +1.71% | 186.81K | $723.87M | $4.35 - $14.00 | 0.00% |
| 54 | Sana BiotechnologySANA | $2.38 | -1.44% | 869.34K | $711.63M | $2.22 - $5.49 | 0.00% |
| 55 | Attovia TherapeuticsATTO | $17.27 | +0.84% | 10.23K | $697.09M | $12.94 - $28.00 | 0.00% |
| 56 | 4D MolecularFDMT | $12.51 | +1.00% | 112.27K | $690.83M | $6.96 - $16.93 | 0.00% |
| 57 | Ginkgo BioworksDNA | $11.73 | -0.58% | 721.19K | $649.93M | $5.37 - $18.22 | 0.00% |
| 58 | NRC HealthNRC | $26.64 | -0.45% | 13.64K | $565.34M | $11.73 - $27.41 | 0.02% |
| 59 | Entera BioENTX | $3.24 | -0.31% | 53.42K | $563.68M | $0.91 - $4.20 | 0.00% |
| 60 | RegenxbioRGNX | $8.42 | +10.92% | 523.88K | $555.96M | $5.46 - $16.19 | 0.00% |
| 61 | IRulya Therapeutics Inc.IRLA | $42.40 | +7.46% | 58.72K | $459.68M | $25.13 - $44.54 | 0.00% |
| 62 | Tectonic TherapeuticTECX | $22.05 | +0.91% | 39.05K | $430.97M | $16.77 - $39.53 | 0.00% |
| 63 | AlectorALEC | $2.83 | +8.50% | 996.33K | $420.58M | $1.09 - $2.83 | 0.00% |
| 64 | C4CCCC | $3.00 | -1.48% | 774.88K | $393.30M | $1.69 - $5.17 | 0.00% |
| 65 | Editas MedicineEDIT | $2.48 | -1.40% | 724.94K | $380.11M | $1.66 - $3.94 | 0.00% |
| 66 | SurrozenSRZN | $32.38 | -0.70% | 50.68K | $375.92M | $11.73 - $37.83 | 0.00% |
| 67 | Fennec Pharmaceuticals Inc.FENC | $10.55 | -0.61% | 46.12K | $371.69M | $5.65 - $13.25 | 0.00% |
| 68 | 艾吉纳斯AGEN | $7.14 | +2.92% | 108.41K | $322.50M | $2.71 - $10.31 | 0.00% |
| 69 | Kyverna TherapeuticsKYTX | $5.18 | +2.36% | 175.02K | $320.53M | $4.50 - $13.67 | 0.00% |
| 70 | Eikon TherapeuticsEIKN | $6.36 | +2.04% | 55.24K | $319.57M | $5.01 - $17.40 | 0.00% |
| 71 | X4 PharmaceuticalsXFOR | $3.22 | +0.15% | 452.73K | $319.25M | $2.43 - $4.83 | 0.00% |
| 72 | OcugenOCGN | $0.94 | -0.97% | 2.05M | $318.61M | $0.69 - $2.73 | 0.00% |
| 73 | Century TherapeuticsIPSC | $1.72 | +2.68% | 61.28K | $310.54M | $0.43 - $3.04 | 0.00% |
| 74 | Allogene TherapeuticsALLO | $0.89 | -3.36% | 4.67M | $308.18M | $0.88 - $4.46 | 0.00% |
| 75 | Scribe TherapeuticsSCTX | $17.64 | +1.32% | 71.11K | $297.23M | $13.50 - $39.60 | 0.00% |
| 76 | SAB BiotherapeuticsSABS | $3.10 | +0.98% | 484.38K | $282.06M | $2.44 - $5.15 | 0.00% |
| 77 | Lexeo TherapeuticsLXEO | $3.12 | +2.61% | 62.02K | $255.98M | $2.55 - $10.99 | 0.00% |
| 78 | Precision BioSciencesDTIL | $9.11 | -4.21% | 113.67K | $254.47M | $3.53 - $11.29 | 0.00% |
| 79 | Cabaletta BioCABA | $1.43 | -2.41% | 1.14M | $241.60M | $1.18 - $4.23 | 0.00% |
| 80 | ProKidneyPROK | $1.15 | +4.50% | 243.51K | $239.28M | $0.87 - $2.88 | 0.00% |
| 81 | InhibikaseIKT | $1.60 | +3.87% | 75.66K | $223.26M | $1.40 - $2.61 | 0.00% |
| 82 | Fate TherapeuticsFATE | $1.70 | -4.52% | 1.06M | $206.00M | $0.95 - $3.23 | 0.00% |
| 83 | Palisade BioPALI | $1.16 | +3.10% | 546.36K | $201.28M | $1.08 - $2.85 | 0.00% |
| 84 | Artiva BiotherapeuticsARTV | $4.10 | +1.35% | 203.36K | $200.45M | $2.96 - $14.53 | 0.00% |
| 85 | Alpha CognitionACOG | $9.00 | +1.95% | 21.36K | $195.96M | $4.50 - $10.14 | 0.00% |
| 86 | InvivydIVVD | $0.59 | +5.21% | 457.89K | $173.61M | $0.53 - $3.07 | 0.00% |
| 87 | Sutro BiopharmaSTRO | $10.14 | +1.67% | 28.76K | $168.22M | $7.15 - $43.85 | 0.00% |
| 88 | HumacyteHUMA | $0.60 | +3.42% | 4.11M | $167.51M | $0.34 - $1.52 | 0.00% |
| 89 | Protara TherapeuticsTARA | $2.67 | +10.08% | 302.41K | $157.49M | $2.09 - $7.82 | 0.00% |
| 90 | Compass Therapeutics,CMPX | $0.82 | -1.89% | 486.76K | $148.57M | $0.67 - $6.88 | 0.00% |
| 91 | Zura Bio LimitedZURA | $1.52 | +7.83% | 3.19M | $146.90M | $0.93 - $7.44 | 0.00% |
| 92 | LENZ TherapeuticsLENZ | $4.24 | +3.66% | 178.07K | $133.22M | $2.80 - $32.13 | 0.00% |
| 93 | enGene TherapeuticsENGN | $1.75 | +1.80% | 167.44K | $117.48M | $1.40 - $12.25 | 0.00% |
| 94 | MaxCyteMXCT | $1.14 | +1.33% | 690.09K | $117.14M | $0.64 - $1.80 | 0.00% |
| 95 | OUTLOOK THERAPEUTICSOTLK | $0.48 | +4.56% | 1.21M | $116.37M | $0.16 - $2.54 | 0.00% |
| 96 | Voyager TherapeuticsVYGR | $1.78 | -2.19% | 199.99K | $110.52M | $1.68 - $5.48 | 0.00% |
| 97 | Anavex Life SciencesAVXL | $1.11 | -1.33% | 234.90K | $103.36M | $1.06 - $7.25 | 0.00% |
| 98 | Tevogen Bio HoldingsTVGN | $5.93 | +2.33% | 648 | $93.40M | $3.64 - $24.91 | 0.00% |
| 99 | Coherus BioSciencesCHRS | $0.59 | -5.57% | 1.54M | $91.93M | $0.59 - $2.62 | 0.00% |
| 100 | Black DiamondBDTX | $1.58 | -5.65% | 335.38K | $91.06M | $1.58 - $4.94 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。